Live Breaking News & Updates on Graphite Bio Inc

Stay updated with breaking news from Graphite bio inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director Purchases $15,000,075.27 in Stock

LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) Director Ra Capital Management, L.P. purchased 998,009 shares of the stock in a transaction that occurred on Thursday, March 21st. The stock was acquired at an average cost of $15.03 per share, for a total transaction of $15,000,075.27. Following the completion of the acquisition, the director now […] ....

Therapeutics Company Profile , Securities Exchange Commission , Graphite Bio Inc , Lenz Therapeutics Inc , Therapeutics Inc , Get Free Report , Director Ra Capital Management , Exchange Commission , Bio Inc , Lenz Therapeutics , Nasdaq Lenz , Insider Trading , Nsider Trades ,

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director Acquires $15,000,075.27 in Stock

LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) Director Ra Capital Management, L.P. purchased 998,009 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The shares were purchased at an average price of $15.03 per share, for a total transaction of $15,000,075.27. Following the completion of the transaction, the director […] ....

Therapeutics Inc , Lenz Therapeutics Inc , Graphite Bio Inc , Therapeutics Company Profile , Get Free Report , Director Ra Capital Management , Bio Inc ,